6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with mepivacaine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirota, K; Kusunoki, M; Matsuo, Y; Nishi, K; Okamoto, A; Oku, K; Shingu, K; Sumi, C; Takenaga, K; Tanaka, M | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and mepivacaine
Article | Year |
---|---|
The antioxidant N-acetyl cysteine suppresses lidocaine-induced intracellular reactive oxygen species production and cell death in neuronal SH-SY5Y cells.
Topics: Acetylcysteine; Anesthetics, Local; Antioxidants; Apoptosis; Bupivacaine; Cell Death; Cell Line, Tumor; Cell Survival; Chromans; Dose-Response Relationship, Drug; HeLa Cells; Humans; Lidocaine; Membrane Potential, Mitochondrial; Mepivacaine; Mitochondria; Neuroblastoma; Reactive Oxygen Species; Time Factors | 2016 |